Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice: a cross-sectional study based on French and Italian prescribing data

BackgroundAsthma is often poorly controlled and guidelines are often inadequately followed in medical practice. In particular, the prescription of non-asthma-specific drugs can affect the quality of care. The goal of this study was to measure the frequency of the prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients and to look for associations between sex or age and the prescription of these drugs.MethodsA cross-sectional study was conducted using computerised medical records from French and Italian general practitioners’ networks. Patients were selected according to criteria adapted from the HEDIS (Healthcare Effectiveness Data and Information Set) criteria. The outcome measure was the number of antibiotics or anxiolytics/hypnotics prescriptions per patient in 1 year. Parallel multivariate models were developed.ResultsThe final sample included 3,093 French patients (mean age 27.6 years, 49.7% women) and 3,872 Italian patients (mean age 29.1 years, 48.7% women). In the univariate analysis, the French patients were prescribed fewer antibiotics than the Italian patients (37.1% vs. 42.2%, p < 0.00001) but more anxiolytics/hypnotics (17.8% vs. 6.9%, p < 0.0001). In the multivariate models, the female patients were more likely to receive antibiotics (odds ratio: 1.5 [1.3–1.7]) and anxiolytics/hypnotics (odds ratio: 1.8 [1.5–2.1]).ConclusionsThe prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients is frequent, especially in women. Asthma guidelines should address this issue by referring to other guidelines covering the prescription of non-asthma-specific drugs, and alternative non-pharmacological interventions should be considered.

[1]  P. Correll,et al.  Impact of asthma on self-reported health status and quality of life: a population based study of Australians aged 18–64 , 2005, Thorax.

[2]  F. Haaijer-Ruskamp,et al.  Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. , 2000, The European respiratory journal.

[3]  F. Fagnani,et al.  Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy. , 2004, Joint, bone, spine : revue du rhumatisme.

[4]  R. Kessler,et al.  Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[5]  S. Weich,et al.  Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study , 2014, BMJ : British Medical Journal.

[6]  L. Fabbri,et al.  Macrolides for chronic asthma. , 2005, The Cochrane database of systematic reviews.

[7]  L. Salinger,et al.  Asthma in pregnancy. , 1990, NAACOG's clinical issues in perinatal and women's health nursing.

[8]  C. Lemière,et al.  Validity of asthma diagnoses recorded in the Medical Services database of Quebec , 2006, Pharmacoepidemiology and drug safety.

[9]  C. Shuldham,et al.  Psychological interventions for adults with asthma: a systematic review. , 2007, Respiratory medicine.

[10]  R. Araya,et al.  Common mental disorders in Santiago, Chile , 2001, British Journal of Psychiatry.

[11]  G. Mazzaglia,et al.  Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. , 2003, Journal of public health medicine.

[12]  J. Lepine,et al.  Prévalence et comorbidité des troubles psychiatriques dans la population générale française : résultats de l’étude épidémiologique ESEMeD/MHEDEA 2000/ (ESEMeD) , 2005 .

[13]  M. Pisani,et al.  Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  C. Butler,et al.  Antibiotics for sinusitis-like symptoms in primary care , 2008, The Lancet.

[15]  P. Nafstad,et al.  A prospective study of asthma and subsequent use of hypnotics in young adults , 2011, Pharmacoepidemiology and drug safety.

[16]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[17]  M. Ohayon,et al.  Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. , 2002, The Journal of clinical psychiatry.

[18]  I. Ovhed,et al.  What is the future of primary care research? , 2005, Scandinavian journal of primary health care.

[19]  Alastair D Hay,et al.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[20]  Kayleigh Kew,et al.  Macrolides for chronic asthma. , 2015, The Cochrane database of systematic reviews.

[21]  F. Dubois,et al.  Arrêté du 28 juillet 2009 relatif à la composition du Conseil national de l'ordre des médecins , 2009 .

[22]  J. Astbury,et al.  Gender disparities in mental health , 2001 .

[23]  C. Lundborg,et al.  Variations in asthma treatment in five European countries--judgement analysis of case simulations. , 2002, Family Practice.

[24]  G. Trifirò,et al.  Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data. , 2008, Pharmacological research.

[25]  L. George,et al.  Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. , 1991, American journal of public health.

[26]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[27]  H. Ashton Psychotropic-Drug Prescribing for Women , 1991, British Journal of Psychiatry.

[28]  B. Ditto,et al.  What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? , 2006, Chest.

[29]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[30]  L. Osman,et al.  Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  Pierre Ernst,et al.  Increased risk of childhood asthma from antibiotic use in early life. , 2007, Chest.

[32]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[33]  C. van Weel,et al.  Family practices registration networks contributed to primary care research. , 2006, Journal of clinical epidemiology.

[34]  Herman Goossens,et al.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. , 2011, The Journal of antimicrobial chemotherapy.

[35]  T. Pirilä,et al.  Sinus aspirates and radiographic abnormalities in severe attacks of asthma. , 1994, International archives of allergy and immunology.

[36]  R. Churchill,et al.  Psychological therapies for generalised anxiety disorder. , 2007, The Cochrane database of systematic reviews.

[37]  C J Homer,et al.  Relationship between asthma medication and antibiotic use. , 2001, Chest.

[38]  J. Bousquet,et al.  How appropriate is asthma therapy in general practice? , 2005, Fundamental & clinical pharmacology.

[39]  S. Suissa,et al.  Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers , 1996, BMJ.

[40]  H. Goossens,et al.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[41]  C. O'brien Benzodiazepine use, abuse, and dependence. , 2005, The Journal of clinical psychiatry.

[42]  P. Morris,et al.  WITHDRAWN: Antibiotics for persistent nasal discharge (rhinosinusitis) in children. , 2008, The Cochrane database of systematic reviews.

[43]  J. Lépine,et al.  [Prevalence and comorbidity of psychiatric disorders in the French general population]. , 2005, L'Encephale.

[44]  G. Nocea,et al.  Asthma-related resource use and cost by GINA classification of severity in three European countries. , 2006, Respiratory medicine.

[45]  J P Ornato,et al.  Clinical prediction rule for pulmonary infiltrates. , 1990, Annals of internal medicine.

[46]  P. Demoly,et al.  Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years , 2012, European Respiratory Review.

[47]  W. Geerts,et al.  The Management of Asthma: A Case-Scenario-Based Survey of Family Physicians and Pulmonary Specialists , 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.

[48]  Philip Marcus,et al.  Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.